| Impaired gastric ulcer healing in diabetic mice: role of methylglyoxal. | |
| | |
MedLine Citation:
|
PMID: 20388955 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Methylglyoxal is a reactive dicarbonyl compound produced from cellular glycolytic intermediates that reacts non-enzymatically with proteins to form products such as argpyrimidine at arginine residue. The aim of the present study was to investigate the role of methylglyoxal in the delayed healing of gastric ulcer in diabetes, and to identify the methylglyoxal-modified proteins as a target molecule of this modification. Using male C57BL/6 mice, diabetes was induced by a single i.p. injection of streptozotocin and gastric ulcers were produced by the focal application of 40% of acetic acid to the serosal surface of the stomach. In order to evaluate the effect of OPB-9195, an inhibitor of methylglyoxal modification, on gastric ulcer healing, mice were given orally OPB-9195 (30 mg/kg) twice daily for 14 days, one week before and after the injection of streptozotocin. The area of gastric ulcer on day 7 was significantly increased in diabetic mice compared to non-diabetic mice, indicating delayed ulcer healing. This increase in ulcer area in diabetic mice was significantly reversed by the treatment with OPB-9195 without affecting blood glucose levels. Proteomics analysis showed the methylglyoxal-modification of peroxiredoxin 6 proteins in the diabetic gastric mucosa around gastric ulcer, and this modification was markedly inhibited by the treatment with OPB-9195. In conclusion, the present study suggests a link of increased methylglyoxal modification of proteins including peroxiredoxin 6 to the delayed gastric ulcer healing in diabetes, and also shows the therapeutic potential of the inhibitor of methylglyoxal modification for the treatment of diabetic gastric ulcers. |
| | |
Authors:
|
Y Naito; T Takagi; T Oya-Ito; H Okada; T Suzuki; I Hirata; M Hirai; K Uchiyama; O Handa; K Uchida; T Yoshikawa |
Related Documents
:
|
1688815 - Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surfac... 468615 - Effects of methacholine and hypocapnia on airways and collateral ventilation in dogs. 11827435 - Gastric emptying in an animal model of human diabetes type 1: relation to endocrine cells. 9352855 - Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontan... 20557415 - The impact of diabetes education on blood glucose self-monitoring among older adults. 9292635 - Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society Volume: 60 Suppl 7 ISSN: 1899-1505 ISO Abbreviation: J. Physiol. Pharmacol. Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2010-04-14 Completed Date: 2010-08-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9114501 Medline TA: J Physiol Pharmacol Country: Poland |
Other Details:
|
Languages: eng Pagination: 123-30 Citation Subset: IM |
Affiliation:
|
Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan. ynaito@koto.kpu-m.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Ulcer Agents / therapeutic use Blood Glucose / analysis, drug effects Diabetes Mellitus, Experimental / complications, pathology, physiopathology* Gastric Mucosa / chemistry, drug effects, pathology, physiology Glycosylation / drug effects Glycosylation End Products, Advanced / analysis, antagonists & inhibitors, physiology* Male Mice Mice, Inbred C57BL Ornithine / analogs & derivatives, analysis Peroxiredoxin VI / chemistry, metabolism Protein Processing, Post-Translational / drug effects, physiology Proteins / analysis, chemistry Pyrimidines / analysis Pyruvaldehyde / antagonists & inhibitors, metabolism* Regeneration / drug effects, physiology Severity of Illness Index Stomach Ulcer / chemically induced, drug therapy, physiopathology*, prevention & control Thiadiazoles / therapeutic use Thiazolidines / therapeutic use Wound Healing / drug effects, physiology* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Ulcer Agents; 0/Blood Glucose; 0/Glycosylation End Products, Advanced; 0/OPB 9195; 0/Proteins; 0/Pyrimidines; 0/Thiadiazoles; 0/Thiazolidines; 0/argpyrimidine; 7006-33-9/Ornithine; 78-98-8/Pyruvaldehyde; EC 1.11.1.15/Peroxiredoxin VI; EC 1.11.1.15/Prdx6 protein, mouse |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antiinflammatory effect of BPC 157 on experimental periodontitis in rats.
Next Document: Beta-carotene inhibits Helicobacter pylori-induced expression of inducible nitric oxide synthase and...